The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is one of the most common malignancy with poor prognosis, and the mortality rate remains high. More than 70% of HCC patients have recurrence within 5 years after treatment. The purpose of this study is to evaluate the prognostic values of serum mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bo, Liu, Aixia, Wen, Yi, Yang, Guang, Zhao, Jing, Li, Xiaohan, Mao, Yuanli, Li, Boan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418514/
https://www.ncbi.nlm.nih.gov/pubmed/34403527
http://dx.doi.org/10.1002/jcla.23932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418514/
https://www.ncbi.nlm.nih.gov/pubmed/34403527
http://dx.doi.org/10.1002/jcla.23932

Ejemplares similares